Individuals at risk of anaphylaxis—an acute systemic hypersensitivity reaction to an allergen or trigger, typically associated with skin reactions, nausea/vomiting, difficulty breathing, and shock—are ...
Epinephrine Injection (Auto-Injector) is a prescription medicine in a disposable, prefilled automatic injection device (auto-injector) used to treat life-threatening, allergic emergencies including ...
Lineage's epinephrine auto-injector is the only generically priced epinephrine auto-injector currently available. This authorized generic epinephrine injection, USP auto-injector, is being ...
Anaphylaxis is a serious, potentially life-threatening allergic reaction that can affect several organ systems in the body and may threaten breathing and blood circulation. The most common causes of ...
People with severe allergies now have more choices for which epinephrine auto-injector to carry in case they suffer a life-threatening attack, and most pay less for it than they did when the EpiPen ...
The U.S. Food and Drug Administration today approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including those ...
Please provide your email address to receive an email when new articles are posted on . Epinephrine autoinjectors may have little effect on surviving anaphylaxis events. Research is needed in ...
The U.S. Food and Drug Administration (FDA) has approved Richmond-based Kaléo’s supplemental drug application for the first epinephrine auto-injector specifically for infants and children with serious ...
Potential milestone payments could bring Intelliject’s take to $230 million. Sanofi-aventis obtained the rights to Intelliject’s epinephrine auto-injector for the emergency treatment of anaphylaxis in ...
Epinephrine nasal spray alongside auto-injectors will now be permitted in Tennessee schools, thanks to a new law aimed at improving responses to allergic reactions.
JERUSALEM & PARSIPPANY, N.J.--(BUSINESS WIRE)-- Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today announced availability of the FDA-approved generic version of EpiPen Jr®1 (epinephrine ...
Individuals at risk of anaphylaxis—an acute systemic hypersensitivity reaction to an allergen or trigger, typically associated with skin reactions, nausea/vomiting, difficulty breathing, and shock—are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results